Circulating SCCA–IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients
暂无分享,去创建一个
G. Fassina | N. Caporaso | M. Guarino | F. Morisco | A. Gallotta | C. Tuccillo | R. Tortora | G. D. Di Costanzo | F. Auriemma | L. Paneghetti